Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

Click for more information

0.00%

20.5¢ resapp health limited

yep I agree with all of that. My first post was just stating ce...

First 28 Last

Share
Profile

Follow
havana19

431 Posts.

33

02/01/19

14:40

Post #: 37003863
Share

Originally posted by AussieCash ↑

I agree with you on the fact that achieving a CE mark does not guarantee revenues (to any company in the world in fact).

However, to market and 'to go out and sell' a medical device in a number of countries, a CE mark is necessary and it requires clinical evidence which RAP has built over the last few years.

It will be up to the RAP team to bring in revenues.
If you believe in the current management team then it is a matter of when rather than if revenues will start flowing in.
And unfortunately it is taking much longer than RAP, and myself, were expecting back in 2015. My take is that revenues are 18 months delayed due to the failed trials in 2017; if CE and FDA submissions go to plan and schedule this time then we should see some deals happening by December 2019. RAP has a goal of making $20m by June 2020 for the performance shares to be issued, still achievable.

Expand

yep I agree with all of that. My first post was just stating ce marking does not equate to revenue, and some idiots got a bee in their Bonet about it. Wouldn't it be nice if we could all just start up businesses and make bucket loads of money upon attaining ce marking.

Last edited by havana19: 02/01/19

RAP Price at posting: 11.0¢ Sentiment: Sell Disclosure: Not Held
6 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 580 more messages in this thread...

First 28 Last

Add RAP (ASX) to my watchlist